These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8092835)

  • 1. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani.
    Chen M; Christensen SB; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1339-44. PubMed ID: 8092835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
    Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
    J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
    Chen M; Christensen SB; Blom J; Lemmich E; Nadelmann L; Fich K; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2550-6. PubMed ID: 8109916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel arylimidamides for treatment of visceral leishmaniasis.
    Wang MZ; Zhu X; Srivastava A; Liu Q; Sweat JM; Pandharkar T; Stephens CE; Riccio E; Parman T; Munde M; Mandal S; Madhubala R; Tidwell RR; Wilson WD; Boykin DW; Hall JE; Kyle DE; Werbovetz KA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2507-16. PubMed ID: 20368397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
    Al-Abdely HM; Graybill JR; Loebenberg D; Melby PC
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2910-4. PubMed ID: 10582881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.
    Chen M; Zhai L; Christensen SB; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2023-9. PubMed ID: 11408218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani.
    Zhang R; Shang L; Jin H; Ma C; Wu Y; Liu Q; Xia Z; Wei F; Zhu XQ; Gao H
    Parasitol Res; 2010 Jul; 107(2):475-9. PubMed ID: 20495931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis.
    de Mello TF; Cardoso BM; Lopes SN; Bitencourt HR; Voltarelli EM; Hernandes L; Aristides SM; Lonardoni MV; Silveira TG
    Parasitol Res; 2015 Oct; 114(10):3587-600. PubMed ID: 26096827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.
    Berman JD; Hanson WL; Chapman WL; Alving CR; Lopez-Berestein G
    Antimicrob Agents Chemother; 1986 Dec; 30(6):847-51. PubMed ID: 3813512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
    Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S
    J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
    Kar S; Kar K; Bhattacharya PK; Ghosh DK
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.
    Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG
    Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental treatment with sodium stibogluconate of hamsters infected with Leishmania (Leishmania) chagasi and Leishmania (Leishmania) amazonensis.
    de Figueiredo EM; Costa e Silva J; Brazil RP
    Rev Soc Bras Med Trop; 1999; 32(2):191-3. PubMed ID: 10228371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a bis(benzyl)polyamine analogue, and DL-alpha-difluoromethylornithine on parasite suppression and cellular polyamine levels in golden hamster during Leishmania donovani infection.
    Mukhopadhyay R; Madhubala R
    Pharmacol Res; 1993 Dec; 28(4):359-65. PubMed ID: 8140036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
    Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
    Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog.
    Baumann RJ; Hanson WL; McCann PP; Sjoerdsma A; Bitonti AJ
    Antimicrob Agents Chemother; 1990 May; 34(5):722-7. PubMed ID: 2360812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
    Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
    Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
    Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.